The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksFutura Medical Share News (FUM)

Share Price Information for Futura Medical (FUM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.70
Bid: 39.25
Ask: 39.95
Change: 2.90 (7.88%)
Spread: 0.70 (1.783%)
Open: 37.80
High: 39.70
Low: 37.80
Prev. Close: 36.80
FUM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Anglo-Eastern tips palm oil price fall; DX expands

Mon, 28th Jun 2021 19:35

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

Anglo-Eastern Plantations PLC - palm oil and rubber producer in Indonesia and Malaysia - Says production of fresh fruit bunches in five months to May 31 up 16% year-on-year. Says crude palm oil output 26% higher and CPO price average USD1,120 per metric tonne, up 70% year-on-year. "The group expects prices to moderate in the second half of the year on the back of higher crop production. CPO prices are also expected to weaken by a pull back in prices of competing soybean oil due to better weather ameliorating crop concerns in the United States, as well as likely lower biofuel targets," Anglo-Eastern adds.

----------

DX Group PLC - Slough, England-based mail, courier and logistics company - Expands in north east of England with new depot in Middlesbrough for its DX Express unit. Company adds: "The new depot, located in Riverside Park Industrial Park, replaces a smaller site in Hartlepool, and will become the centre of operations in the region for the DX Express division. DX Express offers a range of highly secure, tracked and express delivery services for documents, pouches and parcels to both B2B and B2C end-customers."

----------

Zinnwald Lithium PLC - High Wycombe, England-based mineral exploration and development company - Chair Jeremy Martin at annual general meeting notes company has sealed acquisition of Deutsche Lithium GmbH and completed initial testwork of lithium hydroxide project. Says "highly encouraging" early results. "As we continue to advance the project, its permitting and financing, we believe the 100% ownership structure has significant benefits, including providing our shareholders with greater exposure to the project's long-term value," Martin adds.

----------

Condor Gold PLC - Surrey, England-based gold exploration and development company - Reports "significant" drill intercept of 25.93 metres at 3.94 grammes per tone of gold, from depth of 263.82 metres, at Cacao prospect, Nicaragua. "This is the best drilling intercept returned to-date from the Cacao prospect," company says. "This assay result supports the geological model that Cacao is a fully preserved, deep-seated epithermal gold mineralisation system, with the potential to host a significant gold deposit."

----------

Caerus Mineral Resources PLC - exploration & resource development company - Agrees terms to buy Cyprus Gold Mines Ltd, an exploration and mining firm with three copper-gold assets. Deal values CGML at GBP300,000, payable on completion.

----------

Prospex Energy PLC - exploration investment company with core investments in Spain and Italy - Says 83% of holders agree to rollover 2018 loan note into new unsecured 2021 note. Says terms largely unchanged but repayment date extended by 18 months and interest rate upped to 12% from 10%. "Board believes high uptake of rollover reflects progress made across European gas and power portfolio," Prospex says.

----------

Quadrise Fuels International PLC - supplier of emulsion technology and cleaner fuels - Seeing interest in bioMSAR fuel oil alternative "from all segments of the energy market that are targeted". Quadrise adds: "This is creating significant demand in the sector for low carbon emissions and renewable fuels, incentivising Quadrise to further accelerate its bioMSAR testing, development and production plans."

----------

Mosman Oil & Gas Ltd - London-based metals exploration and development company - Says Falcon-1 well, Texas continues to produce gas and oil with only "small" quantity of water. Well has now produced average of 114 barrels of oil equivalent per day of gas and seven barrels of oil per day of condensate. Total of 121 boepd over past five days. Mosman adds: "Gas continues to be sold utilizing the existing pipeline facilities, and oil is transported off site by truck."

----------

i3 Energy PLC - oil & gas company with assets and operations in the UK and Canada - Says A-52-G horizontal gas well at Noel acreage in British Columbia brought on-stream earlier in June. Production from well averages 650 barrels of oil equivalent per day, exceeding expectations by 30%. Says Marten Hills 01-12-075-26W4 well spud on June 15. CEO Majid Shafiq says: "We are very pleased with the initial production performance of the Noel well, which has exceeded expectations, will contribute to year-end reserves additions and has de-risked similar offsetting drilling locations. Operations in Marten Hills have proceeded exceptionally well and we look forward to bringing these wells onto production in late July."

----------

Chesterfield Resources PLC - London-based company focused on discovery and development of copper deposits - Begins diamond drilling in Cyprus, exploring for copper, gold, silver and zinc. "The programme is expected to cover approximately 2,000m of drilling," Chesterfield adds.

----------

Tertiary Minerals PLC - mineral exploration and development company - Element-46 Ltd says reservation notice for exploration permit at Kalkkinen Prospect, Finland cancelled on environmental grounds. Tertiary adds: "The company has been advised by E46 that the licence reservation was not granted, the company will not be entitled to receive the E46 shares, and the future royalty interest referred to in the prior announcement will fall away."

----------

Altus Strategies PLC - mining royalty company - Says further targets outlined at Tabakorole gold project in Mali. Adds 3,000 metre diamond drilling programme completed, with results pending. CEO Steven Poulton says: "Ground magnetic and soil sampling surveys have successfully defined numerous additional targets at the Tabakorole gold project in southern Mali. Marvel Gold, our ASX listed JV partner, is aggressively advancing the project, with drilling currently targeting near-surface, high-grade intercepts that fall outside of the previously modelled mineralisation."

----------

Aura Energy Ltd - Australia-based minerals company - Calls on MinCore Engineers Pty Ltd to begin work to update capital estimate for definitive feasibility study of Tiris uranium project. "The capital estimate update will reflect 2021 input costs allowing a clear path to the near-term development of Tiris project," Aura says. "Completion of capital estimate update expected in first week of July 2021."

----------

Power Metal Resources PLC - London-based metals exploration and development company - First phase of work programme has begun at gold-nickel properties in the Tati greenstone belt, Botswana. "Power Metal has an option to acquire a 100% interest in the Tati projects through its local wholly owned operating subsidiary Power Metal Resources Botswana Pty Ltd," Power Metal says.

----------

SDX Energy PLC - London-headquartered oil and gas exploration, production, and development company - Completes initial three well phase of 2021 drilling campaign in Morocco. Total programme consists of five wells. "I am pleased to announce that the company has successfully drilled the first three wells of its 2021 drilling activities which will total up to eleven wells across our portfolio of assets. The OYF-3, KSR-17 and KSR-18 wells in Morocco were all commercial successes, and OYF-3 and KSR-17 are already connected and producing into our infrastructure," Chief Executive Officer Mark Reid says. "In Egypt we are expecting to commence the drilling of the IY-2 step out development well at South Disouq in the coming days, and our planning for the potentially transformational HA-1X exploration well is significantly progressed, with spud expected in Q3 2021."

----------

Oakley Capital Investments Ltd - investment vehicle offering access to Oakley Funds - Says Oakley Capital Private Equity III reaches deal to sell stake in ACE Education, a vocational higher education platform in France and Spain. Oakley Capital says its share of proceeds to be around GBP16 million. As part of deal, Oakley Capital Origin Fund to invest GBP40 million, alongside media firm Groupe Amaury and ACE founder Patrick Touati. Oakley Capital's contribution via Origin Fund to be about GBP10 million.

----------

Riverstone Credit Opportunities Income PLC - makes senior secured loans to small and middle-market energy companies - Realises Project Chase investment. In July 2019, company committed USD12.3 million to an exploration firm focused on dry gas window of Eagle Ford basin. Riverstone adds: "30% of the loan was paid down in April 2021, and on 25 June 2021, the remainder was fully realised." No longer has exposure to exploration and production sector.

----------

VietNam Holding Ltd - investment firm focussed on high-growth companies in Vietnam - Exited its position in ABA through full repayments of bonds and interest on June 25. Back in July 2019, VNH made VND139.8 billion investment in ABA through convertible bonds. "The investment was a private-equity transaction, structured with a negotiated set of terms and conditions, including the right to convert into equity once the foreign ownership limits allowed, and once there was the visibility of a listing, and yet provide downside protection in the form of full redemption in the event that there was not a listing event imminent," VietNam says. In late 2020, VNH decided against exercising conversion and instead asked for repayment. Company adds: "The realisation does not have a material impact on VNH's net asset value."

----------

NFT Investments PLC - investment in non-fungible tokens - Reports "excellent progress" despite "difficult trading conditions in the crypto market". Says since April 16 AQSE float, bitcoin tumbles to USD31,200 as of June 26 from USD63,000. "This has also impacted asset values in the non-fungible tokens market; for example, the price of Flow has fallen by approximately 78% from USD36 to USD8 over the same period," NFT says. "However, NFT's highly selective and cautious investment policy, together with the board's considerable industry experience, has positioned the company to take advantage of the unexpected industry correction at more attractive valuations as and when investment conditions stabilise."

----------

FastForward Innovations Ltd - Guernsey-based investment company - Invests further AUD2.8 million, about GBP1.5 million, in Sydney-listed portfolio firm Little Green Pharma Ltd. Now has 3.2% stake in medicinal cannabis firm. In addition, company sells 18,183 shares in Portage Biotech Inc, netting USD732,952, and representing a gain of USD551,000.

----------

Tern PLC - internet of things-focused investor - Investee Wyld Networks AB to receive SEK25 million, about GBP2.1 million, from initial public offering in Stockholm.

----------

Bluefield Solar Income Fund Ltd - Guernsey-based income fund that invests primarily in solar assets - Strikes conditional agreement to acquire 109 small scale UK onshore wind turbines for GBP60 million. Also has prospect of increasing investment by further GBP35 million to re-power 17 turbines in Northern Ireland. Also announces GBP100 million placing, open offer and offer for subscription at 118 pence each.

----------

Impact Healthcare REIT PLC - real estate investment trust focused on healthcare properties - Inks GBP26 million loan facility with NatWest, with accordion option to up financing to GBP50 million. Loan has three year term, with option of two added years. Has yearly margin of 190 basis points above SONIA. "At the same time, the group has agreed to repay GBP10 million of its GBP25 million term loan with Metro Bank PLC," Impact adds.

----------

Futura Medical PLC - Surrey-based pharmaceutical company - Notes MED3000 erectile dysfunction treatment has CE approval mark in Europe, paving way for green light in Middle East, Africa, the Far East and Latin America. "For the US, planning and preparation activities such as active site recruitment are well underway for the start of FM71, the confirmatory study to be conducted prior to formal regulatory submission to FDA as a de-novo medical device. Trial start is on schedule with first patient dosing expected Q3 2021," Futura says.

----------

MyHealthChecked PLC - Cardiff-based consumer home-testing healthcare - Buys genetic testing and nutrition consultancy firm Nell Health Ltd for initial GBP1.2 million, mostly in shares and GBP50,000 in cash. Notes a deferred consideration of GBP1.0 million, performance-based and payable in shares. "Nell Health, based in New Covent Garden Market, has developed an innovative technology platform that offers users personalised accessible and actionable outcomes to improve health and wellness based on information gathered from a Nell Health DNA test. Customers taking a test are provided with diet and exercise insights by experts, based on the analysis of DNA relating to nutrition including food intolerance, potential vitamin deficiencies and exercise types that suit that individual's body," MyHealthChecked says.

----------

Renalytix PLC - Cardiff, Wales-based clinical diagnostics for kidney disease - Says new data shows KidneyIntelX platform can monitor therapeutic response and kidney health in adults with type 2 diabetes. "By accurately assessing therapeutic response, particularly in patients at high risk for kidney failure, KidneyIntelX can potentially address a major barrier for primary care physicians and specialists in using new pharmaceuticals to slow kidney disease and improve outcomes," company says.

----------

Nanoco Group PLC - Manchester, England-based heavy-metal-free quantum dots manufacturer - Updates on litigation against Samsung Electronics Co over alleged intellectual property infringement. Calls on Eastern District of Texas to delay court trial for Samsung patent infringement claim until Patent Trial & Appeal Board makes decision of inter partes reviews. Nanoco explains: "IPRs are a standard part of IP litigation and examine the validity of the patents themselves." Company adds: "A ruling in favour of the joint motion is expected shortly. It is expected that a trial will be re-scheduled for late 2022 once the outcome of the IPRs is known."

----------

PCF Group PLC - parent of PCF Bank Ltd, serving individuals and small businesses - Says 2020 report audit issues relate to intercompany transfers and balances as well as issues related to funding provided by PCF Bank to unit Azule Ltd. PCF adds: "The board is very disappointed and concerned by these findings and is determined to ensure that the PCF Group adheres fully to the high standards of financial control and reporting expected by it and also by its regulators, shareholders and other key stakeholders. The board is urgently taking steps to remediate the deficiencies identified in financial controls and corporate governance and has commenced work to ensure that a clear plan is in place to enhance PCF Group's corporate governance." Announces restructuring of senior leadership team, including appointment of chief risk officer and general counsel. Also plans to recruit "additional colleagues with "skills and experience required for a listed bank". Company says trading continuing as normal. PCF says: "Covid-related payment deferral levels continue to reduce and the performance of its lending portfolio is in line with expectations."

----------

RTW Venture Fund Ltd - investment company focused on the life sciences sector - Portfolio firm GH Research PLC raises USD160 million in initial public offering of 10 million shares at USD16.00 each. GH's shares rose 20% on first day of trading to close at USD19.25 a share.

----------

Totally PLC - healthcare services provider across the UK and Ireland - Wins new contract worth GBP850,000. Will provide endoscopy procedures to Saolta Group of Hospitals in Galway, Republic of Ireland, covering six hospitals. "Totally Healthcare will help the hospitals to shorten patient waiting lists, which have increased significantly throughout the Covid-19 pandemic with non-urgent procedures being delayed," Totally says. "Contract commences in July 2021 and runs until March 2022."

----------

Tissue Regenix Group PLC - regenerative medical devices company - Completes phase one expansion plans to increase capacity at San Antonio, Texas facilities. Tissue adds: "The remaining aspects of phase one consisted of expanding the space for supporting administrative departments, which has taken place in the company's leased facility adjacent to its existing facility, and building and qualifying two additional clean rooms, which are in the company's existing facility."

----------

Apollon Formularies PLC - London-based medical cannabis company - Says its medicinal cannabis formulations successful in killing triple-negative breast cancer cells in lab setting. "The testing results showed that Apollon Jamaica's medical cannabis formulations were effective in killing living triple-negative cancer cells directly (direct cytotoxicity). The Apollon medical cannabis formulations killed nearly 100% of the triple negative breast cancer cells in 3D cell cultures," Apollon says.

----------

Genus PLC - Basingstoke, Hampshire-based company that sells products made using biotechnology to cattle and pig farmers - Says porcine genetics unit PIC enters into strategic pact with shareholders of Spanish porcine genetic distributor Sergal Gestio Ramadera SL. "Sergal is a leading porcine distributor in Spain and its high quality supply chain, commitment to customer service and innovative culture make it an ideal partner to enhance the distribution of PIC's elite porcine genetics in the Spanish and European markets," Genus says. PIC to acquire Sergal's semen supply chain. "Within the EU, the pig herd in Spain continues to expand year on year due to strong domestic demand and a focus on exports. Spain continues to be one of the key global pork markets exporting to China," Genus says.

----------

Guild Esports PLC - e-sports business headquartered in London - Wins third major esports trophy, with Fortnite player Tai Starcic winning Fortnite Champion All-Star Showdown. Prize money from event totalled USD167,000. "To see Guild win a third major trophy in such quick succession is incredible. The hard work and dedication everyone has put in, from our players and coaches to sports psychologists, is delivering world-class results in some of the biggest esports tournaments. This latest victory is also a testament to Guild's academy model which is aiding players to consistently perform at their best," CEO Kal Hourd says.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
9 Aug 2023 12:07

IN BRIEF: Futura Medical's ED treatment approved in Saudi Arabia

Futura Medical PLC - Surrey, England-based pharmaceutical company - Says its distribution partner, Labatec Pharma, received regulatory approval for MED3000 in Saudi Arabia. MED3000 is Futura's topical, gel-based erectile dysfunction treatment. Labatec will exclusively launch and commercialise MED3000 under the brand name Eroxon, with initial launch planned in the final quarter of 2023. Adds the manufacturing of Eroxon for launch has been completed.

Read more
18 Jul 2023 14:16

Futura Medical chair steps down, promotes non-executive director

(Alliance News) - Futura Medical PLC on Tuesday said it appointed Non-Executive Chair Jeff Needham as the successor to outgoing chair John Clarke, who has stepped down.

Read more
17 Jul 2023 09:13

Futura Medical agrees US licensing deal with Haleon for Med3000 gel

(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US.

Read more
17 Jul 2023 08:33

Futura Medical shares rise on ED licensing deal with Haleon

(Sharecast News) - Shares in Futura Medical gained on Monday after the company said it signed a licensing deal with consumer heath care giant Haleon for the rights to exclusively commercialise its topical, gel-based erectile dysfunction treatment MED3000 in the USA.

Read more
22 Jun 2023 14:45

IN BRIEF: Futura Medical hails continued momentum after Eroxon launch

Futura Medical PLC - Guildford, Surrey-based pharmaceutical company - Says it is encouraged by the early growth trajectory of erectile dysfunction treatment gel Eroxon following its recent launch. "Both initial orders of Eroxon by our partners and in-market demand have been in line with our expectations and should continue to build as partners expand sales channels, numbers of outlets and new geographies," it adds. Predicts that net revenue for the six months ending June 30 will be no less than GBP1.5 million. Says momentum continues to build as it enters the commercialisation phase and positions itself to receive its first significant revenue in 2023. It previously in April said that its 2022 pretax loss widened to GBP6.9 million from GBP5.8 million the year before.

Read more
15 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Friday 16 June 
Alpha Growth PLCAGM
Anglo-Eastern Plantations PLCAGM
Gulf Keystone Petroleum LtdAGM
John Lewis of Hungerford PLCGM re proposed cancellation of admission to trading on AIM
Tesco PLCAGM
Woodbois LtdAGM
Monday 19 June 
All ThingsConsidered Group PLCAGM
Blackbird PLCAGM
Finsbury Food Group PLCAGM
Globalworth Real Estate Investments LtdAGM
Marlowe PLCGM re proposed capital reduction
Metals Exploration PLCAGM
Red Rock Resources PLCGM re security conversion into shares for cash
Savannah Resources PLCAGM
Tuesday 20 June 
Acceler8 Ventures PLCAGM
Afentra PLCAGM
Armadale Capital PLCAGM
Bay Capital PLCAGM
Blackrock Smaller Companies Trust PLCAGM
Block Energy PLCAGM
Corero Network Security PLCAGM
Coro Energy PLCAGM
Crimson Tide PLCAGM
Curtis Banks Group PLCAGM
EPE Special Opportunities LtdAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Jersey Oil & Gas PLCAGM
Kore Potash PLCAGM
Lords Group Trading PLCAGM
Mission Group PLCAGM
North Atlantic Smaller Cos Investment Trust PLCAGM
Red Capital PLCAGM
Saga PLCAGM
SDX Energy PLCAGM
Skillcast Group PLCAGM
Zegona Communications PLCAGM
Wednesday 21 June 
Argentex Group PLCAGM
Clean Power Hydrogen PLCAGM
Eqtec PLCAGM
Hydrogen Utopia International PLCAGM
HSS Hire Group PLCAGM
Intelligent Ultrasound Group PLCAGM
JD.com IncAGM
RTW Venture Fund LtdAGM
Schroders Capital Global Innovation Trust PLCAGM
Sivota PLCAGM
Numis Corp PLCGM re acquisition by Deuche Bank AG
THG PLCAGM
UK Commercial Property REIT LtdAGM
Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM

 

Read more
12 Jun 2023 12:08

LONDON MARKET MIDDAY: Stocks firm as expected Fed pause still in doubt

(Alliance News) - Stock prices in London were tentatively higher at midday on Monday, as investors looked ahead to a key US inflation print on Tuesday with some caution ahead of the Federal Reserve's next interest rate decision.

Read more
12 Jun 2023 10:13

AIM WINNERS & LOSERS: Ovoca Bio drops as Orenetide study delayed

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.

Read more
12 Jun 2023 09:47

Futura shares jump after FDA approval for erectile dysfunction product

(Alliance News) - Futura Medical PLC said on Monday that the US Food & Drug Administration granted over the counter sale marketing authorising for MED3000, the company's treatment of erectile dysfunction.

Read more
18 Apr 2023 13:09

Futura's erection gel launched over-the-counter in the UK

(Sharecast News) - Sexual health-focussed pharmaceutical company Futura Medical announced on Tuesday that its topical gel formulation for the treatment of erectile dysfunction (ED), MED3000, is now available in the UK under the 'Eroxon' brand.

Read more
18 Apr 2023 12:32

Futura launches Eroxon erectile dysfunction gel in UK stores

(Alliance News) - Futura Medical PLC announced on Tuesday that its erectile dysfunction treatment gel Eroxon is now available for purchase in the UK.

Read more
5 Apr 2023 12:21

Futura Medical annual loss widens as eyes MED3000 progress

(Alliance News) - Futura Medical PLC said on Wednesday its annual loss widened as it focused on the commercialisation of its new MED3000 product.

Read more
29 Mar 2023 15:48

UK earnings, trading statements calendar - next 7 days

Thursday 30 March 
AO World PLCTrading Statement
Aquis Exchange PLCFull Year Results
Arbuthnot Banking Group PLCFull Year Results
Ascential PLCFull Year Results
BBGI Global Infrastructure SAFull Year Results
Chesnara PLCFull Year Results
Ebiquity PLCFull Year Results
Gattaca PLCHalf Year Results
Gresham House PLCFull Year Results
IGas Energy PLCFull Year Results
Impellam Group PLCFull Year Results
International Public Partnerships LtdFull Year Results
Ithaca Energy PLCFull Year Results
Microlise Group PLCFull Year Results
Moonpig Group PLCTrading Statement
PetroTal CorpFull Year Results
Renalytix PLCHalf Year Results
Revolution Beauty Group PLCFull Year Results
Robinson PLCFull Year Results
Secure Trust Bank PLCFull Year Results
Supermarket Income REIT PLCHalf Year Results
XLMedia PLCFull Year Results
Friday 31 March 
Amaroq Minerals LtdFull Year Results
Bank of Cyprus Holdings PLCFull Year Results
Computacenter PLCFull Year Results
Cooks Coffee Co LtdFull Year Results
CT Private Equity Trust PLCFull Year Results
Dignity PLCFull Year Results
ECO Animal Health Group PLCTrading Statement
HealthBeacon PLCFull Year Results
Impax Environmental Markets PLCFull Year Results
James Halstead PLCHalf Year Results
Jaywing PLCTrading Statement
JPMorgan American Investment Trust PLCFull Year Results
Numis Corp PLCTrading Statement
Mothercare PLCTrading Statement
Quarto Group IncFull Year Results
UK Oil & Gas PLCFull Year Results
Vanquis Banking Group PLCFull Year Results
Monday 3 April 
Downing Renewables & Infrastructure Trust PLCFull Year Results
Elixirr International PLCFull Year Results
Fidelity Japan Trust PLCFull Year Results
Gaming Realms PLCFull Year Results
HydrogenOne Capital Growth PLCFull Year Results
N4 Pharma PLCFull Year Results
Renew Holdings PLCTrading Statement
Tracsis PLCHalf Year Results
Tuesday 4 April 
accesso Technology Group PLCFull Year Results
Anexo Group PLCTrading Statement
Epwin Group PLCFull Year Results
Merchants Trust PLCFull Year Results
Renewi PLCTrading Statement
Saga PLCFull Year Results
Wednesday 5 April 
EnQuest PLCFull Year Results
Futura Medical PLCFull Year Results
Hilton Food Group PLCFull Year Results
Lookers PLCFull Year Results
Lords Group Trading PLCFull Year Results
RS Group PLCTrading Statement
Topps Tiles PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
29 Mar 2023 09:52

IN BRIEF: Futura responds to US FDA on erectile dysfunction treatment

Futura Medical PLC - Surrey, England-based sexual health-focused pharmaceutical company - Says it has submitted a full response to questions from the US Food & Drug Administration and confirmatory data regarding its MED3000 erectile dysfunction treatment. This is for the FDA to continue its review of the product. Notes that it expects the grant of the De Novo request in the second quarter of 2023. A De Novo classification by the FDA provides an alternate pathway to marketing approval for novel medical devices.

Read more
14 Mar 2023 14:33

Futura Medical confirms Europe launch of MED3000; awaits FDA approval

(Alliance News) - Futura Medical PLC on Tuesday said its MED3000 product is now available online in Europe under the brand name Erexon.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account